Drug Profile
Research programme: cerebral infarction therapeutic - Shin Nippon Biomedical/Nagasaki University
Alternative Names: Cerebroprotective peptide - Shin Nippon Biomedical Laboratories/Nagasaki UniversityLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nagasaki University School of Medicine; Shin Nippon Biomedical Laboratories
- Class Peptides
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cerebral infarction
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cerebral-infarction in Japan
- 21 Mar 2013 Preclinical trials in Cerebral infarction in Japan (unspecified route)